You are here

TECHLAB, INC.

Company Information
Address
2001 KRAFT DR
BLACKSBURG, VA -
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Point-of-Care Diagnostic Test for Entamoeba histolytica Cysts

    Amount: $599,260.00

    DESCRIPTION (provided by applicant): The NIAID Category B priority pathogen Entamoeba histolytica is a public health threat, especially as a cause of diarrhea in travelers to and immigrants from endem ...

    STTRPhase I2012Department of Health and Human Services National Institutes of Health
  2. Alum-absorbed subunit vaccine to prevent intestinal amebiasis

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): We propose to produce a subunit vaccine for Entamoeba histolytica and test it in mice for immunogenicity and for protection from intestinal amebiasis. Entamoeba h ...

    SBIRPhase I2011Department of Health and Human Services National Institutes of Health
  3. Multiplex Diagnostic for Enteric Category B Pathogens and Intestinal Biomarkers

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Our goal is development of a multiplex immunodiagnostic panel specific for Giardia, Cryptosporidium, E. histolytica, and shiga toxin-producing Shigella and E. coli ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health
  4. New Rapid Diagnostic Tests for Amebiasis

    Amount: $2,000,000.00

    DESCRIPTION (provided by applicant): Our goal is to produce point-of-care diagnostic tests for amebiasis. Entamoeba histolytica is a protozoan parasite and the causative agent of amebiasis in humans. ...

    STTRPhase II2009Department of Health and Human Services National Institutes of Health
  5. Multiplex Screening ELISA for Giardia, Cryptosporidium and E. histolytica

    Amount: $1,590,500.00

    DESCRIPTION (provided by applicant): Our specific objective with this fast-track STTR application is a diagnostic screen for the NIAID Biodefense Category B intestinal pathogens Giardia lamblia, Crypt ...

    STTRPhase I2008Department of Health and Human Services National Institutes of Health
  6. Mucin-degrading microflora for prophylactic antibiotics

    Amount: $274,969.00

    DESCRIPTION (provided by applicant): This resubmitted Phase I SBIR application focuses on the development of a mucin-degrading colonic flora that competitively excludes Clostridium difficile, a gram-p ...

    SBIRPhase I2007Department of Health and Human Services National Institutes of Health
  7. New Rapid Diagnostic Tests for Amebiasis

    Amount: $2,000,000.00

    DESCRIPTION (provided by applicant): Entamoebga histolytica is a protozoan parasite and the causative agent of amebiasis in humans. Intestinal amebiasis causes debilitating diarrhea and dysentery, whi ...

    SBIRPhase II2006Department of Health and Human Services National Institutes of Health
  8. New Diagnostics for Amebiasis

    Amount: $979,495.00

    DESCRIPTION (provided by applicant): Entamoeba histolytica, the cause of amoebiasis, is a Category B pathogen considered in the top three biodefense parasites because it is difficult to diagnose. The ...

    SBIRPhase I2004Department of Health and Human Services National Institutes of Health
  9. C. difficile Toxin Membrane Test with Magnetic Particles

    Amount: $464,426.00

    DESCRIPTION (provided by applicant): The use of paramagnetic particles (PMP) and their detection in a magnetic assay reader (MAR) represent a new "platform" technology that is adaptable to lateral flo ...

    SBIRPhase I2003Department of Health and Human Services National Institutes of Health
  10. N/A

    Amount: $242,801.00

    N/A

    SBIRPhase I2000Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government